Hypertension and Diabetes

References

• Stern N., Tuck M. L. Mechanisms of hypertension in Diabetes Mellitus. Hypertension: Pathophysiology, Diagnosis, and Management, J. H. Laragh, B. Brenner. Raven Press, New York 1990; 1689–1702
   Google Scholar
• Stein P. P., Black H. R. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991; 14: 425–448
   PubMed Web of Science ®Google Scholar
• Sowers J. R., Khoury S. Diabetes and hypertension: a review. Primary Care 1991; 18: 509–524
   PubMed Web of Science ®Google Scholar
• Arauz-Pacheco C., Raskin P. Management of hypertension in diabetes. Endocrinology and Metabolism Clinics of North America (Vol. 21), J. Karam. W.B. Saunders Publishing Co., Toronto 1992; 371–394
   Google Scholar
• Stamler J., Vaccaro O., Neaton J. D., Wentworth D. (for the Multiple Risk Factor Intervention Trial Research Group), Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434–444
   PubMed Web of Science ®Google Scholar
• Tai T. Y., Chuang L. M., Chen C. J., Lin B. J. Link between hypertension and diabetes mellitus epidemiological study of Chinese adults in Taiwan. Diabetes Care 1991; 14: 1013–1020
   PubMed Web of Science ®Google Scholar
• Fuller J. H., Head J. Blood pressure, proteinuria and their relationship with circulatory mortality: the WHO multinational study of vascular disease in diabetics. Diabete Metab 1989; 15: 273–277
   PubMed Web of Science ®Google Scholar
• Morales P. A., Mitchell B. D., Valdez R. A., Hazuda H. P., Stern M. P., Haffner S. M. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects - The San Antonio Heart Study. Diabetes 1993; 42: 154–161
   PubMed Web of Science ®Google Scholar
• Grossman E., Shemesh J., Shamiss A., Thaler M., Carroll J., Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med 1992; 152: 1001–1004
   PubMed Web of Science ®Google Scholar
• Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613–616
   PubMed Web of Science ®Google Scholar
• Devereux R. B. Detection of left ventricular hypertrophy by M-mode echocardiography: anatomic validation, standardization and comparison to other methods. Hypertension 1987; 9(Suppl. II)119–1126
   Google Scholar
• Strowig S., Raskin P. Glycemic control and diabetic complications. Diabetes Care 1992; 15: 1126–1140
   PubMed Web of Science ®Google Scholar
• Seaquist E. R., Goetz F. C., Rich S., Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161–1165
   PubMed Web of Science ®Google Scholar
• Hamet P. Metabolic aspects of hypertension. Hypertension: Physiopathology and Treatment (2nd Ed.), J. Genest, O. Kuchel, P. Hamet, M. Cantin. McGraw-Hill, New York 1983; 408–427
   Google Scholar
• Weidmann P., Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care 1991; 14: 220–232
   PubMed Web of Science ®Google Scholar
• Fioretto P., Sambataro M., Cipollina M. R., Giorato C., Carraro A., Opocher G., Sacerdoti D., Brocco E., Morocutti A., Mantero F., Gatta A., Nosadini R. Role of atrial natriuretic peptide in the pathogenesis of sodium retention in IDDM with and without glomerular hyperfiltration. Diabetes 1992; 41: 936–945
   PubMed Web of Science ®Google Scholar
• Resnick L. M. Cellular ions in hypertension, insulin resistance, obesity, and diabetes: a unifying theme. J Am Soc Nephrol 1992; 3: S78–S85
   PubMed Web of Science ®Google Scholar
• Trevisan R., Fioretto P., Semplicini A., Opocher G., Mantero F., Rocco S., Remuzzi G., Morocutti A., Zanette G., Donadon V., Perico N., Giorato C., Nosadini R. Role of insulin and atrial natriuretic peptide in sodium retention in insulin-treated IDDM patients during isotonic volume expansion. Diabetes 1990; 39: 289–298
   PubMed Web of Science ®Google Scholar
• Trevisan R., Li L. K., Messent J., Tariq T., Earle K., Walker J. D., Viberti G. Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 1992; 41: 1239–1246
   PubMed Web of Science ®Google Scholar
• Umeda F., Franks D. J., Sugimoto H., Halle J. P., Hamet P. Effect of plasma, serum and platelets from diabetics on DNA synthesis in cultured vascular smooth muscle cells. Clin Invest Med 1985; 8: 35–40
   PubMed Web of Science ®Google Scholar
• Sugimoto H., Franks D. J., Lecavalier L., Chiasson J. L., Hamet P. Therapeutic modulation of growth-promoting activity in platelets from diabetics. Diabetes 1987; 36: 667–672
   PubMed Web of Science ®Google Scholar
• Hadrava V., Kruppa U., Russo R. C., Tremblay J., Hamet P. Vascular smooth muscle cell proliferation and its therapeutic modulation in hypertension. Am Heart J 1991; 122: 1198–1203
   PubMed Web of Science ®Google Scholar
• Koschinsky T., Bunting C. E., Rutter R., Gries F. A. Vascular growth factors and the development of macrovascular disease in diabetes mellitus. Diabete Metab 1987; 13: 318–325
   PubMed Web of Science ®Google Scholar
• Mikhail N., Tremblay J., Hamet P. L'insuline exerce un effet prolifératif prononcé sur les cellules de la musculature lisse vasculaire d'aortes provenant de rats génétiquement hypertendus. Dijon, Alfediam 1993
   Google Scholar
• Moore W. V., Donaldson D. L., Chonko A. M., Ideus P., Wiegmann T. B. Ambulatory blood pressure in type I diabetes mellitus - Comparison to presence of incipient nephropathy in adolescents and young adults. Diabetes 1992; 41: 1035–1041
   PubMed Web of Science ®Google Scholar
• Klein R., Klein B. E.K., Moss S. E., Davis M. D., Demets D. L. Is blood pressure a predictor of the incidence or progression of diabetic retinophathy?. Arch Intern Med 1989; 149: 2427–2432
   PubMed Web of Science ®Google Scholar
• Lurbe A., Redon J., Pascual J. M., Tacons J., Alvarez V. D.C.Ï Altered blood pressure during sleep in normotensive subjects with type I diabetes. Hypertension 1993; 21: 227–235
   PubMed Web of Science ®Google Scholar
• Mattock M. B., Morrish N. J., Viberti G., Keen H., Fitzgerald A. P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 41: 736–741
   PubMed Web of Science ®Google Scholar
• Schwab S. J., Dunn F. L., Feinglos M. N. Screening for microalbuminuria - A comparison of single sample methods of collection and techniques of albumin analysis. Diabetes Care 1992; 15: 1581–1584
   PubMed Web of Science ®Google Scholar
• Parving H. H., Smidt U., Andersen A. R., Svendsen P. A. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175–1179
   PubMed Web of Science ®Google Scholar
• Brouhard B. H. Antihypertensive therapy for patients with diabetes mellitus. Diabetes Care 1992; 15: 918–921
   PubMed Web of Science ®Google Scholar
• Taguma Y., Kitamoto Y., Futaki G., Ueda H., Monma H., Ishizaki M., Takahashi H., Sekino H., Sasaki Y. Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 1985; 313: 1617–1620
   PubMed Web of Science ®Google Scholar
• Mimran A., Insua A., Ribstein J., Bringer J., Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy. Diabetes Care 1988; 11: 850–853
   PubMed Web of Science ®Google Scholar
• Parving H. H., Hommel E., Nielsen M. D., Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy. Br Med J 1989; 299: 533–536
   PubMed Web of Science ®Google Scholar
• Stornello M., Valvo E. V., Scapellato L. Hemodynamic, renal, and humoral effects of the calcium entry blocker nicardipine and converting enzyme inhibitor captopril in hypertensive type II diabetic patients with nephropathy. J Cardiovasc Pharmacol 1989; 14: 851–855
   PubMed Web of Science ®Google Scholar
• Mathiesen E. R., Hommel E., Giese J., Parving H. H. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81–87
   PubMed Web of Science ®Google Scholar
• Hommel E., Parving E. H.H., Edsberg B., Nielsen M. D., Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 293: 467–470
   PubMed Web of Science ®Google Scholar
• Bjorck S., Nyberg G., Mulec H., Granerus G., Herlitz H., Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471–474
   PubMed Web of Science ®Google Scholar
• Valvo E. N., Bedogna V., Casagrande P., Antiga L., Zamboni M., Bommartini F., Oldrizei L., Rugiu C., Maschio G. Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alteration. Am J Med 1988; 85: 344–348
   PubMed Web of Science ®Google Scholar
• Marre M., Leblanc H., Suarez L., Guyenne T. T., Menard J., Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 1987; 294: 1448–1452
   PubMed Web of Science ®Google Scholar
• Baba T., Murabayashi S., Takebe K. Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial. Diabetologia 1989; 32: 40–44
   PubMed Web of Science ®Google Scholar
• Morelli E., Loon N., Meyer T., Peters W., Myers B. D. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990; 39: 76–82
   PubMed Web of Science ®Google Scholar
• Bjorck S., Mulec H., Johnsen S. A., Nyberg G., Aurell M. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy. Br Med J 1992; 300: 904–907
   Web of Science ®Google Scholar
• Rudberg S., Aperia A., Freyschuss U., Person B. Enalapril reduces microalbuminuria in young normotensive type I (insulin-dependent) diabetic patients irrespective of its hypotensive effect. Diabetologia 1990; 33: 470–476
   PubMed Web of Science ®Google Scholar
• Stornello M., Valvo E. V., Scapellato L. Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetics patients affected by arterial hypertension and persistent proteinuria. Nephron 1991; 58: 52–57
   PubMedGoogle Scholar
• Bakris G. L. Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 112: 707–708
   PubMed Web of Science ®Google Scholar
• Allen T., Cooper M., Jerums G., De Luise M., Alford F., Doyle A., Hammond J., Mashford M., Mc Menamin C., Mohr M., Raffaele J., Westwood B. (Melbourne Diabetic Nephropathy Study Group). Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Br Med J 1991; 302: 210–216
   PubMed Web of Science ®Google Scholar
• Demarie B. K., Bakris G. L. Effects of different calcium antagonists on proteinuriz associated with diabetes mellitus. Ann Intern Med 1990; 113: 987–988
   PubMed Web of Science ®Google Scholar
• Gambardella S., Frontoni S., Lala A., Felici M. G., Spallone V., Scoppola A., Jacoangeli F., Menzinger G. Regression of microalbuminuria in type II diabetic, hypertensive patients after long-term indapamide treatment. Am Heart J 1991; 122: 1232–1238
   PubMed Web of Science ®Google Scholar
• Flack J. R., Molyneaux L., Willey K., Yue D. X. Regression of microalbuminuria: results of a controlled study, indapamide versus captopril. J Cardiovasc Pharmacol 1993, in press
   PubMed Web of Science ®Google Scholar
• Hamet P., Kalant N., Ross S. A., Wilson T. W., Leenen F. H., Haynes B. Recommendations from the Canadian Hypertension Society Consensus Conference on Hypertension and Diabetes. Can Med Assoc J 1988; 139: 1059–1062
   Web of Science ®Google Scholar
• Myers M. G., Carruthers S. G., Leenen F. H.H., Haynes R. B. Recommendations from the Canadian Hypertension Society Consensus Conference on the pharmacologic treatment of hypertension. Can Med Assoc J 1989; 140: 1141–1146
   Web of Science ®Google Scholar
• Dawson K., Mc Kenzie J. K., Ross S. A., Chiasson J. L., Hamet P. Consensus Conference Report - Therapy of Hypertension - Revised Recommendations on Hypertension and Diabetes, the Canadian Hypertension Society Consensus. Can Med Assoc J 1993, in press
   Web of Science ®Google Scholar
• Eriksson K. F., Lindgarde F. Contribution of estimated insulin resistance and glucose intolerance to essential hypertension. J Internal Med 1991; 229(Suppl. 2)75–83
   Google Scholar
• Warram J. H., Laffel L. M.B., Valsania P., Christlieb A. R., Krolewski A. S. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991; 151: 1350–1356
   PubMed Web of Science ®Google Scholar
• Randeree H. A., Omar M. A.K., Motala A. A., Seedat M. A. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure. Diabetes Care 1992; 15: 1258–1263
   PubMed Web of Science ®Google Scholar
• Tjoa H. I., Kaplan N. M. Nonpharmacological treatment of hypertension in diabetes mellitus. Diabetes Care 1991; 14: 449–460
   PubMed Web of Science ®Google Scholar